Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease

Cell Host and Microbe

Volumn 23, Issue 6, 2018, Pages 716-724

  Agus, Allison ^a   Planchais, Julien ^a   Sokol, Harry ^a,b  

^a UMR1319 MICALIS   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

AhR; autism; cerative colitis; Crohn disease; gut microbiota; IBD; kynurenine; serotonin; tryptophan metabolism

Indexed keywords

SEROTONIN; TRYPTOPHAN; INDOLE DERIVATIVE; KYNURENINE;

HOST PATHOGEN INTERACTION; HUMAN; IMMUNITY; INFECTION; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; INTESTINE FUNCTION; IRRITABLE COLON; MENTAL DISEASE; METABOLIC REGULATION; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PHYSICAL DISEASE; PRIORITY JOURNAL; REVIEW; TRYPTOPHAN METABOLISM; AUTISM; COLITIS; COMMUNICABLE DISEASE; CROHN DISEASE; GASTROINTESTINAL TRACT; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SHORT BOWEL SYNDROME;

AUTISTIC DISORDER; COLITIS; COMMUNICABLE DISEASES; CROHN DISEASE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INDOLES; INFLAMMATORY BOWEL DISEASES; KYNURENINE; METABOLIC SYNDROME; OBESITY; SEROTONIN; SHORT BOWEL SYNDROME; TRYPTOPHAN;

EID: 85047213592     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2018.05.003     Document Type: Review

References (60)

1. Alexeev, E.E., Lanis, J.M., Kao, D.J., Campbell, E.L., Kelly, C.J., Battista, K.D., Gerich, M.E., Jenkins, B.R., Walk, S.T., Kominsky, D.J., et al. Microbiota-derived indole metabolites promote human and murine intestinal homeostasis through regulation of interleukin-10 receptor. Am. J. Pathol. 188 (2018), 1183–1194.
2. Alkhalaf, L.M., Ryan, K.S., Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms. Chem. Biol. 22 (2015), 317–328.
3. Binienda, A., Storr, M., Fichna, J., Salaga, M., Efficacy and safety of serotonin receptor ligands in the treatment of irritable bowel syndrome: a review. Curr. Drug Targets, 19, 2017, 10.2174/1389450119666171227225408.
4. Blacher, E., Levy, M., Tatirovsky, E., Elinav, E., Microbiome-modulated metabolites at the interface of host immunity. J. Immunol. 198 (2017), 572–580.
5. Cervantes-Barragan, L., Chai, J.N., Tianero, M.D., Luccia, B.D., Ahern, P.P., Merriman, J., Cortez, V.S., Caparon, M.G., Donia, M.S., Gilfillan, S., et al. Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells. Science 357 (2017), 806–810.
6. Cervenka, I., Agudelo, L.Z., Ruas, J.L., Kynurenines: tryptophan's metabolites in exercise, inflammation, and mental health. Science, 357, 2017 eaaf9794.
7. Chaves Filho, A.J.M., Lima, C.N.C., Vasconcelos, S.M.M., de Lucena, D.F., Maes, M., Macedo, D., IDO chronic immune activation and tryptophan metabolic pathway: a potential pathophysiological link between depression and obesity. Prog. Neuropsychopharmacol. Biol. Psychiatry 80 (2018), 234–249.
8. Chimerel, C., Emery, E., Summers, D.K., Keyser, U., Gribble, F.M., Reimann, F., Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. 9 (2014), 1202–1208.
9. Clarke, G., McKernan, D.P., Gaszner, G., Quigley, E.M., Cryan, J.F., Dinan, T.G., A distinct profile of tryptophan metabolism along the kynurenine pathway downstream of toll-like receptor activation in irritable bowel syndrome. Front. Pharmacol., 3, 2012, 90.
10. Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R.D., Shanahan, F., Dinan, T.G., Cryan, J.F., The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 18 (2013), 666–673.
11. Crane, J.D., Palanivel, R., Mottillo, E.P., Bujak, A.L., Wang, H., Ford, R.J., Collins, A., Blümer, R.M., Fullerton, M.D., Yabut, J.M., et al. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat. Med. 21 (2015), 166–172.
12. Devlin, A.S., Marcobal, A., Dodd, D., Nayfach, S., Plummer, N., Meyer, T., Pollard, K.S., Sonnenburg, J.L., Fischbach, M.A., Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota. Cell Host Microbe 20 (2016), 709–715.
13. Dodd, D., Spitzer, M.H., Van Treuren, W., Merrill, B.D., Hryckowian, A.J., Higginbottom, S.K., Le, A., Cowan, T.M., Nolan, G.P., Fischbach, M.A., et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551 (2017), 648–652.
14. Fan, W.-T., Ding, C., Xu, N.-N., Zong, S., Ma, P., Gu, B., Close association between intestinal microbiota and irritable bowel syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 36 (2017), 2303–2317.
15. Favennec, M., Hennart, B., Caiazzo, R., Leloire, A., Yengo, L., Verbanck, M., Arredouani, A., Marre, M., Pigeyre, M., Bessede, A., et al. The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity (Silver Spring) 23 (2015), 2066–2074.
16. Fitzgerald, P., Cassidy Eugene, M., Clarke, G., Scully, P., Barry, S., Quigley Eamonn, M.M., Shanahan, F., Cryan, J., Dinan Timothy, G., Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterol. Motil. 20 (2008), 1291–1297.
17. Fujisawa, T.X., Nishitani, S., Iwanaga, R., Matsuzaki, J., Kawasaki, C., Tochigi, M., Sasaki, T., Kato, N., Shinohara, K., Association of aryl hydrocarbon receptor-related gene variants with the severity of autism spectrum disorders. Front. Psychiatry, 7, 2016, 184.
18. Galligan, J.J., Beneficial actions of microbiota-derived tryptophan metabolites. Neurogastroenterol. Motil., 30, 2018, 10.1111/nmo.13283.
19. Gao, J., Xu, K., Liu, H., Liu, G., Bai, M., Peng, C., Li, T., Yin, Y., Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front. Cell. Infect. Microbiol., 8, 2018, 13.
20. Ghia, J.-E., Li, N., Wang, H., Collins, M., Deng, Y., El-Sharkawy, R.T., Côté, F., Mallet, J., Khan, W.I., Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 137 (2009), 1649–1660.
21. Golubeva, A.V., Joyce, S.A., Moloney, G., Burokas, A., Sherwin, E., Arboleya, S., Flynn, I., Khochanskiy, D., Moya-Pérez, A., Peterson, V., et al. Microbiota-related changes in bile acid & tryptophan metabolism are associated with gastrointestinal dysfunction in a mouse model of autism. EBioMedicine 24 (2017), 166–178.
22. Hodge, S., Bunting, B.P., Carr, E., Strain, J.J., Stewart-Knox, B.J., Obesity, whole blood serotonin and sex differences in healthy volunteers. Obes. Facts 5 (2012), 399–407.
23. Hubbard, T.D., Murray, I.A., Perdew, G.H., Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation. Drug Metab. Dispos. 43 (2015), 1522–1535.
24. Hung, S., Kuo, K., Wu, C., Tarng, D., Indoxyl sulfate: a novel cardiovascular risk factor in chronic kidney disease. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis., 6, 2017, e005022.
25. Hyland, N.P., Quigley, E.M., Brint, E., Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions. World J. Gastroenterol. 20 (2014), 8859–8866.
26. Islam, J., Sato, S., Watanabe, K., Watanabe, T., Ardiansyah, Hirahara, K., Aoyama, Y., Tomita, S., Aso, H., Komai, M., et al. Dietary tryptophan alleviates dextran sodium sulfate-induced colitis through aryl hydrocarbon receptor in mice. J. Nutr. Biochem. 42 (2017), 43–50.
27. Kałużna-Czaplińska, J., Gątarek, P., Chirumbolo, S., Chartrand, M.S., Bjørklund, G., How important is tryptophan in human health?. Crit. Rev. Food Sci. Nutr., 2017, 10.1080/10408398.2017.1357534.
28. Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology 112 (2017), 399–412.
29. Kerckhoffs, A.P.M., ter Linde, J.J.M., Akkermans, L.M.A., Samsom, M., SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 302 (2012), G1053–G1060.
30. Kim, C.J., Kovacs-Nolan, J.A., Yang, C., Archbold, T., Fan, M.Z., Mine, Y., l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J. Nutr. Biochem. 21 (2010), 468–475.
31. Lamas, B., Richard, M.L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T.W., Natividad, J.M., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22 (2016), 598–605.
32. Lamas, B., Natividad, J.M., Sokol, H., Aryl hydrocarbon receptor and intestinal immunity. Mucosal Immunol., 2018, 10.1038/s41385-018-0019-2.
33. Lee, J.-H., Wood, T.K., Lee, J., Roles of indole as an interspecies and interkingdom signaling molecule. Trends Microbiol. 23 (2015), 707–718.
34. Lim, C.K., Essa, M.M., de Paula Martins, R., Lovejoy, D.B., Bilgin, A.A., Waly, M.I., Al-Farsi, Y.M., Al-Sharbati, M., Al-Shaffae, M.A., Guillemin, G.J., Altered kynurenine pathway metabolism in autism: implication for immune-induced glutamatergic activity. Autism Res. 9 (2016), 621–631.
35. Mallmann, N.H., Lima, E.S., Lalwani, P., Dysregulation of tryptophan catabolism in metabolic syndrome. Metab. Syndr. Relat. Disord. 16 (2018), 135–142.
36. Manocha, M., Khan, W.I., Serotonin and GI disorders: an update on clinical and experimental studies. Clin. Transl. Gastroenterol., 3, 2012, e13.
37. Mawe, G.M., Hoffman, J.M., Serotonin signaling in the gastrointestinal tract: functions, dysfunctions, and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 10 (2013), 473–486.
38. Metghalchi, S., Ponnuswamy, P., Simon, T., Haddad, Y., Laurans, L., Clément, M., Dalloz, M., Romain, M., Esposito, B., Koropoulis, V., et al. Indoleamine 2,3-dioxygenase fine-tunes immune homeostasis in atherosclerosis and colitis through repression of interleukin-10 production. Cell Metab. 22 (2015), 460–471.
39. Monteleone, I., Rizzo, A., Sarra, M., Sica, G., Sileri, P., Biancone, L., MacDonald, T.T., Pallone, F., Monteleone, G., Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 141 (2011), 237–248 248.e1.
40. Muller, C.L., Anacker, A.M.J., Veenstra-VanderWeele, J., The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience 321 (2016), 24–41.
41. Nikolaus, S., Schulte, B., Al-Massad, N., Thieme, F., Schulte, D.M., Bethge, J., Rehman, A., Tran, F., Aden, K., Häsler, R., et al. Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology 153 (2017), 1504–1516.e2.
42. O'Farrell, K., Harkin, A., Stress-related regulation of the kynurenine pathway: relevance to neuropsychiatric and degenerative disorders. Neuropharmacology 112:Pt B (2017), 307–323.
43. Oxenkrug, G., Insulin resistance and dysregulation of tryptophan–kynurenine and kynurenine–nicotinamide adenine dinucleotide metabolic pathways. Mol. Neurobiol. 48 (2013), 294–301.
44. Qiu, J., Heller, J.J., Guo, X., Chen, Z.E., Fish, K., Fu, Y.-X., Zhou, L., The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36 (2012), 92–104.
45. Reigstad, C.S., Salmonson, C.E., Rainey, J.F., Szurszewski, J.H., Linden, D.R., Sonnenburg, J.L., Farrugia, G., Kashyap, P.C., Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 29 (2015), 1395–1403.
46. Rothhammer, V., Mascanfroni, I.D., Bunse, L., Takenaka, M.C., Kenison, J.E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and CNS inflammation via the aryl hydrocarbon receptor. Nat. Med. 22 (2016), 586–597.
47. Schiering, C., Wincent, E., Metidji, A., Iseppon, A., Li, Y., Potocnik, A.J., Omenetti, S., Henderson, C.J., Wolf, C.R., Nebert, D.W., et al. Feedback control of AHR signaling regulates intestinal immunity. Nature 542 (2017), 242–245.
48. Schwarcz, R., Bruno, J.P., Muchowski, P.J., Wu, H.-Q., Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 13 (2012), 465–477.
49. Spohn, S.N., Mawe, G.M., Non-conventional features of peripheral serotonin signaling. Nat. Rev. Gastroenterol. Hepatol. 14 (2017), 412–420.
50. Stasi, C., Bellini, M., Bassotti, G., Blandizzi, C., Milani, S., Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech. Coloproctol. 18 (2014), 613–621.
51. Sumara, G., Sumara, O., Kim, J.K., Karsenty, G., Gut-derived serotonin is a multifunctional determinant to fasting adaptation. Cell Metab. 16 (2012), 588–600.
52. Takamatsu, M., Hirata, A., Ohtaki, H., Hoshi, M., Hatano, Y., Tomita, H., Kuno, T., Saito, K., Hara, A., IDO1 plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice. J. Immunol. 191 (2013), 3057–3064.
53. Voigt, J.-P., Fink, H., Serotonin controlling feeding and satiety. Behav. Brain Res. 277 (2015), 14–31.
54. Vujkovic-Cvijin, I., Dunham, R.M., Iwai, S., Maher, M.C., Albright, R.G., Broadhurst, M.J., Hernandez, R.D., Lederman, M.M., Huang, Y., Somsouk, M., et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med., 5, 2013, 193ra91.
55. Williams, B.B., Van Benschoten, A.H., Cimermancic, P., Donia, M.S., Zimmermann, M., Taketani, M., Ishihara, A., Kashyap, P.C., Fraser, J.S., Fischbach, M.A., Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe 16 (2014), 495–503.
56. Wlodarska, M., Luo, C., Kolde, R., d'Hennezel, E., Annand, J.W., Heim, C.E., Krastel, P., Schmitt, E.K., Omar, A.S., Creasey, E.A., et al. Indoleacrylic acid produced by commensal Peptostreptococcus species suppresses inflammation. Cell Host Microbe 22 (2017), 25–37.e6.
57. Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., Nagler, C.R., Ismagilov, R.F., Mazmanian, S.K., Hsiao, E.Y., Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2015), 264–276.
58. Zelante, T., Iannitti, R.G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D'Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385.
59. Zhang, L.S., Davies, S.S., Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med., 8, 2016, 46.
60. Zhang, Y.J., Reddy, M.C., Ioerger, T.R., Rothchild, A.C., Dartois, V., Schuster, B.M., Trauner, A., Wallis, D., Galaviz, S., Huttenhower, C., et al. Tryptophan biosynthesis protects mycobacteria from CD4 T cell-mediated killing. Cell 155 (2013), 1296–1308.